Quantitative metabolomics services for biomarker discovery and validation.
Specializing in ready to use metabolomics kits.
Your source for quantitative metabolomics technologies and bioinformatics.
Loader

Filter by Pathway Type:



Showing 81 - 90 of 605359 pathways
SMPDB ID Pathway Name and Description Pathway Class Chemical Compounds Proteins

SMP0128983

Pw130602 View Pathway

Vosoritide Drug Metabolism

Metabolic

SMP0174497

Missing View Pathway

Vortioxetine Predicted Metabolism Pathway new

Metabolites of Vortioxetine are predicted with biotransformer.
Metabolic
  • Heme
  • Vortioxetine
  • Vortioxetine PIS1M1

SMP0129763

Pw131382 View Pathway

Vorsetuzumab mafodotin Drug Metabolism

Metabolic

SMP0125454

Pw127009 View Pathway

Voriconazole Metabolism

Voriconazole is an triazole antifungal medication used to treat serious, invasive fungal infections. It has increased affinity to 14-alpha sterol demethylase which means it is useful against Fluconazole-resistant organisms. Voriconazole is taken either orally or injected intravenously. The bioavailability of voriconazole is 96%. When taken orally it is transported from the intestine into the intestinal epithelial cell possibly via solute carrier family 15 member 1, one of 3 drug transporters into epithelial cells. It is then transported into blood vessels via ATP-binding cassette sub-family C member 3. It is then transported through the blood to the liver where it is transported in by a liver drug transporter like solute carrier family 22 member 1. On the endoplasmic reticulum membrane Voriconazole is metabolized into Voriconazole N-Oxide by Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 3A4, Cytochrome P450 3A5, or Cytochrome P450 3A7, which makes up 72% of metabolites found. Voriconazole N-Oxide is metabolized into a voriconazole related compound (UK-51,060) by an unknown enzyme. That is predicted by biotransformer to be metabolized by Carbonyl reductase [NADPH] 1 into a similar voriconazole related compound (UK-215,364). That is predicted by biotransformer to be metabolized by UDP-glucuronosyltransferase 1-3 into Voriconazole O-glucuronide derivative (1). Voriconazole also metabolizes into 4-Hydroxyvoriconazole via the enzymes Cytochrome P450 3A4, Cytochrome P450 3A5, or Cytochrome P450 3A7. 4-Hydroxyvoriconazole is predicted by biotransformer to be metabolized by UDP-glucuronosyltransferase 1-3 into 4-Hydroxyvoriconazole 4-O-glucuronide. Voriconazole and all the metabolites are transported out of the liver and into blood vessels by a transport protein such as multidrug resistance-associated protein 4. They all then travel to the kidney where they are excreted in the urine. Less than 2% of the dose is excreted as unchanged voriconazole. 72% is excreted as the metabolite voriconazole N-oxide.
Metabolic

SMP0129203

Pw130822 View Pathway

Voretigene neparvovec Drug Metabolism

Metabolic

SMP0129772

Pw131391 View Pathway

Vopratelimab Drug Metabolism

Metabolic

SMP0130896

Pw132564 View Pathway

Vonoprazan Drug Metabolism

Vonoprazan is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Vonoprazan passes through the liver and is then excreted from the body mainly through the kidney.
Metabolic
  • Vonoprazan

SMP0130163

Pw131782 View Pathway

Vonlerolizumab Drug Metabolism

Metabolic

SMP0129114

Pw130733 View Pathway

Vonicog alfa Drug Metabolism

Metabolic

SMP0128954

Pw130573 View Pathway

Vonapanitase Drug Metabolism

Metabolic
Showing 81 - 90 of 106736 pathways